Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
LATEST IN Big Pharma
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
UMSL awarded $2.4 million grant to continue expanding Succeed Program
The funding will go toward enhancing Succeed programming, strengthening vocational and academic opportunities and improving transition services.
MORE IN Big Pharma
LATEST NEWS
- UMSL awarded $2.4 million grant to continue expanding Succeed Program
- Finance Career Conference offers students opportunity to lead panel, fireside chat sessions
- UMSL Global International Fellowship helps faculty members deepen their research and enrich their teaching
- Eye on UMSL: Tree time
- UMSL Tritons weekly rewind
- Nursing Assistant Teaching Professor Joshua Minks helps support doctoral nursing students through Jonas Scholar Alumni Council
- Information systems student Matt Garland already working as QA analyst at Weissman
- Student Investment Trust portfolio eclipses $1 million plateau
- UMSL Addiction Science Team’s research shows overdose deaths declining in Missouri for second straight year
- Eye on UMSL: Candlelight concert
